These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
UNITED STATES
|
|||||
|
SECURITIES AND EXCHANGE COMMISSION
|
|||||
|
Washington, D.C. 20549
|
|||||
|
SCHEDULE 14A
|
|||||
|
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
|
|||||
|
Filed by the Registrant ☒
|
|||||
|
Filed by a Party other than the Registrant ☐
|
|||||
|
Check the appropriate box:
|
|||||
|
☐
|
|
Preliminary Proxy Statement
|
|||
|
☐
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|||
|
☒
|
|
Definitive Proxy Statement
|
|||
|
☐
|
|
Definitive Additional Materials
|
|||
|
☐
|
|
Soliciting Material Pursuant to §240.14a-12
|
|||
|
UNITY BANCORP, INC.
|
|||||
|
(Name of Registrant as Specified In Its Charter)
|
|||||
|
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
|||||
|
Payment of Filing Fee (Check the appropriate box):
|
|||||
|
☒
|
|
No fee required.
|
|||
|
☐
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|||
|
|
|
(1
|
)
|
|
Title of each class of securities to which transaction applies:
|
|
|
|
(2
|
)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
|
(3
|
)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
(4
|
)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
|
(5
|
)
|
|
Total fee paid:
|
|
☐
|
|
Fee paid previously with preliminary materials.
|
|||
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
|
|||
|
|
|
(1
|
)
|
|
Amount Previously Paid:
|
|
|
|
(2
|
)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
|
(3
|
)
|
|
Filing Party:
|
|
|
|
(4
|
)
|
|
Date Filed:
|
|
1.
|
The election of the
four
(
4
) nominees listed in the attached proxy statement to serve on the Board of Directors for the terms set forth therein for each nominee.
|
|
2.
|
The ratification of the selection of RSM US LLP as the Company’s independent external auditors for the year ending
December 31, 2017
.
|
|
3.
|
The adoption of the Company's 2017 Stock Option Plan.
|
|
4.
|
Such other business as may properly come before the Annual Meeting and at any adjournments thereof, including whether or not to adjourn the Annual Meeting.
|
|
1.
|
The election of the
four
(
4
) nominees listed in the attached proxy statement to serve on the Board of Directors for the terms set forth therein for each nominee.
|
|
2.
|
The ratification of the selection of RSM US LLP as the Company’s independent external auditors for the year ending
December 31, 2017
.
|
|
3.
|
The adoption of the Company's 2017 Stock Option Plan.
|
|
4.
|
Such other business as may properly come before the Annual Meeting and at any adjournments thereof, including whether or not to adjourn the Annual Meeting.
|
|
Name, Age and Position with Company (1)
|
Principal Occupation During Past Five Years
|
Director Since (2)
|
Term Expires
|
|
Wayne Courtright, 69
|
Consultant; Retired, Former Banker
|
2004
|
2020
|
|
Director
|
|
|
|
|
David D. Dallas (3), 62
|
Chairman of the Company and the Bank; Chief Executive Officer
|
1991
|
2020
|
|
Chairman
|
of Dallas Group of America, Inc. (Chemicals)
|
|
|
|
Robert H. Dallas, II (3), 70
|
President of Dallas Group of America, Inc. (Chemicals)
|
1991
|
2020
|
|
Director
|
|
|
|
|
Peter E. Maricondo, 70
|
Retired, Former Financial Consultant; Former Controller at GPU, Inc
|
2004
|
2020
|
|
Director
|
and VP/Corporate Controller at NUI Corporation (Energy)
|
|
|
|
Name, Age and Position with Company (1)
|
Principal Occupation During Past Five Years
|
Director Since (2)
|
Term Expires
|
|
Dr. Mark S. Brody, 64
|
Managing Member Financial Planning Analysts, LLC;
|
2002
|
2018
|
|
Director
|
Vice President of Planned Financial Programs, Inc.
|
|
|
|
Raj Patel, 62
|
President/CEO of Raja Group, a real estate holding company;
|
2007
|
2018
|
|
Director
|
CEO of Millennium Hospitality (Hotel); Founder and Board Member
|
|
|
|
|
of Rainbow Investment Group; and Founder Rainbow Distribution Group
|
|
|
|
Donald E. Souders, Jr., 51
|
Attorney/Partner Florio Perrucci Steinhardt & Fader LLC
|
2007
|
2018
|
|
Director
|
|
|
|
|
Dr. Mary E. Gross, 56
|
Founder, Human Edge Resources, LLC (Human Resource Consulting)
|
2009
|
2019
|
|
Director
|
|
|
|
|
James A. Hughes, 58
|
President and CEO of the Company and the Bank
|
2002
|
2019
|
|
President, CEO and Director
|
|
|
|
|
Aaron Tucker (3), 54
|
President, Tucker Enterprises; Real Estate Builder and Investor
|
2014
|
2019
|
|
Director
|
|
|
|
|
Allen Tucker (3), 90
|
Chairman, Tucker Enterprises; Real Estate Builder and Investor
|
1995
|
2019
|
|
Vice Chairman
|
|
|
|
|
•
|
Developing and recommending to the Board a set of corporate governance principles applicable to the Company, and fulfilling the duties of the Committee as specified in such governance principles;
|
|
•
|
Assisting the Board in determining the size and composition of the Board of Directors and its Committees;
|
|
•
|
Assisting the Board in identifying qualified individuals to be considered for nomination by the Board for election as directors at any meeting of shareholders, including considering proposals made by shareholders and others to nominate specific individuals to the Board of Directors;
|
|
•
|
Overseeing the biennial evaluation of the Board.
|
|
|
2016
|
2015
|
||||
|
Audit fees (1)
|
$
|
233,000
|
|
$
|
237,500
|
|
|
Audit related fees (2)
|
25,022
|
|
31,500
|
|
||
|
Other fees (3)
|
92,500
|
|
11,000
|
|
||
|
Total
|
$
|
350,522
|
|
$
|
280,000
|
|
|
(1)
|
Includes those fees required for reporting on the Company's consolidated financial statements.
|
|
(2)
|
Includes fees related to audits of the Company's employee benefit plans and audit procedures relating to the U.S. Department of Housing and Urban Development (HUD) reporting requirements.
|
|
(3)
|
Includes fees related to filings under the Securities Act of 1933 in both 2016 and 2015.
|
|
Name and Position With Company (1)
|
Number of Shares Beneficially Owned (2)
|
Percent of Class
|
|||
|
Dr. Mark S. Brody, Director
|
384,544
|
|
(3)
|
3.66
|
%
|
|
Wayne Courtright, Director
|
115,480
|
|
(4)
|
1.10
|
%
|
|
David D. Dallas, Chairman
|
1,705,434
|
|
(5)
|
16.22
|
%
|
|
Robert H. Dallas, II, Director
|
1,705,234
|
|
(6)
|
16.22
|
%
|
|
Dr. Mary E. Gross, Director
|
14,943
|
|
(7)
|
0.14
|
%
|
|
Peter E. Maricondo, Director
|
37,245
|
|
(8)
|
0.35
|
%
|
|
Raj Patel, Director
|
33,216
|
|
(9)
|
0.32
|
%
|
|
Donald E. Souders, Jr., Director
|
27,274
|
|
(10)
|
0.26
|
%
|
|
Aaron Tucker, Director
|
34,567
|
|
(11)
|
0.33
|
%
|
|
Allen Tucker, Vice Chairman
|
423,333
|
|
(12)
|
4.03
|
%
|
|
James A. Hughes, President and Director
|
127,695
|
|
(13)
|
1.21
|
%
|
|
Alan J. Bedner, Exec. V.P. and Chief Financial Officer
|
75,061
|
|
(14)
|
0.71
|
%
|
|
Janice Bolomey, Exec. V.P. and Chief Administrative Officer
|
74,717
|
|
(15)
|
0.71
|
%
|
|
John J. Kauchak, Exec. V.P. and Chief Operating Officer
|
111,542
|
|
(16)
|
1.06
|
%
|
|
Directors and Executive Officers of the Company as a Group (14 persons)
|
3,202,541
|
|
(17)
|
29.63
|
%
|
|
5% Shareholders:
|
|
|
|
||
|
Wellington Management Group LLP
|
612,916
|
|
(18)
|
5.89
|
%
|
|
Endicott Management Company
|
660,635
|
|
(19)
|
6.34
|
%
|
|
Banc Funds Company LLC
|
653,769
|
|
(20)
|
6.20
|
%
|
|
(1)
|
The address for Wellington Management Group LLP is 280 Congress Street, Boston, Massachusetts, 02210. The address for Endicott Management Company is 570 Lexington Avenue, 37th Floor, New York, NY 10022. The address for Banc Funds Company LLC is 20 North Wacker Drive, Suite 3300, Chicago, IL 60606-3105. The address for all other listed persons is c/o Unity Bank, 64 Old Highway 22, Clinton, New Jersey, 08809.
|
|
(2)
|
Beneficially owned shares include shares over which the named person exercises either sole or shared voting power or sole or shared investment power. It also includes shares owned (i) by a spouse, minor children or relatives sharing the same home, (ii) by entities owned or controlled by the named person, and (iii) by other persons if the named person has the right to acquire such shares within sixty (60) days by the exercise of any right or option. Unless otherwise noted, all shares are owned of record and beneficially by the named person.
|
|
(3)
|
Includes
48,400
shares held jointly with his spouse, and
14,887
shares issuable upon the exercise of immediately exercisable options. Also includes
40,102
shares registered to Financial Planning Analysts and owned by Dr. Brody;
16,249
shares in Dr. Brody’s own name;
12,705
shares in an SEP-IRA account in his own name; and
247,501
shares held in a master account at Financial Planning Analysts over which Dr. Brody has no voting authority, but has dispositive power. Also includes a total of
4,700
shares of Restricted Stock (see number 21 below for grant details).
|
|
(4)
|
Includes
46,866
shares in Mr. Courtright’s own name,
49,027
shares in an IRA in his own name and
14,887
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
4,700
shares of Restricted Stock (see number 21 below for grant details).
|
|
(5)
|
Includes
17,713
shares in Mr. David Dallas’ own name and
14,887
shares issuable upon the exercise of immediately exercisable options. Shares also disclosed as beneficially owned by Mr. Dallas are
1,667,744
shares held by Dallas Financial Holdings, LLC., which are also disclosed as beneficially owned by Mr. Robert H. Dallas II. Also includes a total of
4,700
shares of Restricted Stock (see number 21 below for grant details) and
390
shares issued through its Dividend Reinvestment Plan.
|
|
(6)
|
Includes
17,713
shares in Mr. Robert Dallas’ own name and
14,887
shares issuable upon the exercise of immediately exercisable options. Shares also disclosed as beneficially owned by Mr. Dallas are
1,667,744
shares held by Dallas Financial Holdings, LLC., which are also disclosed as beneficially owned by Mr. David D. Dallas. Also includes a total of
4,500
shares of Restricted Stock (see number 22 below for grant details) and
390
shares issued through its Dividend Reinvestment Plan.
|
|
(7)
|
Includes
8,776
shares in Dr. Gross’ own name and
1,467
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
4,700
shares of Restricted Stock (see number 21 below for grant details).
|
|
(8)
|
Includes
17,658
shares in Mr. Maricondo’s own name and
14,887
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
4,700
shares of Restricted Stock (see number 21 below for grant details).
|
|
(9)
|
Includes
18,449
shares in Mr. Patel’s own name and
10,267
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
4,500
shares of Restricted Stock (see number 22 below for grant details).
|
|
(10)
|
Includes
7,887
shares in Mr. Souders’ own name;
14,887
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
4,500
shares of Restricted Stock (see number 22 below for grant details).
|
|
(11)
|
Includes
29,260
shares in Mr. Aaron Tuckers’ own name and
1,467
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
3,840
shares of Restricted Stock (see number 23 below for grant details).
|
|
(12)
|
Includes
344,479
shares in Mr. Allen Tucker’s own name;
10,267
shares issuable upon the exercise of immediately exercisable options; and
63,497
shares held by Mr. Tucker’s spouse in her name. Also includes a total of
4,700
shares of Restricted Stock (see number 21 below for grant details) and
390
shares issued through a Dividend Reinvestment Plan.
|
|
(13)
|
Includes
86,304
shares in Mr. Hughes’ own name,
7,597
shares held in his 401(k), and
22,550
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
10,670
shares of Restricted Stock (see number 25 below for grant details) and
574
shares issued through a Dividend Reinvestment Plan.
|
|
(14)
|
Includes
4,947
shares in Mr. Bedner’s own name,
4,114
shares held in his 401(k) and
60,500
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
5,500
shares of Restricted Stock (see number 24 below for grant details).
|
|
(15)
|
Includes
14,189
shares in Ms. Bolomey’s own name and
55,578
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
4,950
shares of Restricted Stock (see number 26 below for grant details).
|
|
(16)
|
Includes
45,157
shares in Mr. Kauchak’s own name and includes
60,885
shares issuable upon the exercise of immediately exercisable options. Also includes a total of
5,500
shares of Restricted Stock (see number 24 below for grant details).
|
|
(17)
|
Includes
312,303
shares issuable upon the exercise of immediately exercisable options.
|
|
(18)
|
All information regarding the number of shares beneficially owned and the percent of ownership by Wellington Management Group LLP, was obtained from the 13G filed with the U.S. Securities and Exchange Commission on February 9, 2017.
|
|
(19)
|
All information regarding the number of shares beneficially owned and the percent of ownership by Endicott Management Company was obtained from Bloomberg on February 21, 2017.
|
|
(20)
|
All information regarding the number of shares beneficially owned and the percent of ownership by Banc Funds Company LLC, was obtained from the 13G filed with the U.S. Securities and Exchange Commission on February 15, 2017.
|
|
(21)
|
The details of the restricted stock grants for all Directors holding
4,700
shares of Restricted Stock as of February 15, 2017 are as follows:
|
|
•
|
660
shares remaining unvested of an original grant of
2,640
shares granted on
November 21, 2013
, which vest in
660
share increments over four (4) years commencing
November 21, 2014
;
|
|
•
|
1,320
shares remaining unvested of an original grant of
2,640
shares granted on
January 2, 2015
, which vest in
660
share increments over four (4) years commencing
January 2, 2016
;
|
|
•
|
1,320
shares remaining unvested of an original grant of
1,760
shares granted on
January 5, 2016
, which vest in
440
share increments over four (4) years commencing
January 5, 2017
; and
|
|
•
|
1,400
shares granted on
January 3, 2017
, which vest in
350
share increments over four (4) years commencing
January 3, 2018
.
|
|
(22)
|
The details of the restricted stock grants for all Directors holding
4,500
shares of Restricted Stock as of February 15, 2017 are as follows:
|
|
•
|
660
shares remaining unvested of an original grant of
2,640
shares granted on
November 21, 2013
, which vest in
660
share increments over four (4) years commencing
November 21, 2014
;
|
|
•
|
1,320
shares remaining unvested of an original grant of
2,640
shares granted on
January 2, 2015
, which vest in
660
share increments over four (4) years commencing
January 2, 2016
;
|
|
•
|
1,320
shares remaining unvested of an original grant of
1,760
shares granted on
January 5, 2016
, which vest in
440
share increments over four (4) years commencing
January 5, 2017
; and
|
|
•
|
1,200
shares granted on
January 3, 2017
which vest in
300
share increments over four (4) years commencing
January 3, 2018
.
|
|
(23)
|
The details of the restricted stock grants for all Directors holding
3,840
shares of Restricted Stock as of February 15, 2017 are as follows:
|
|
•
|
1,320
shares remaining unvested of an original grant of
2,640
shares granted on
January 2, 2015
, which vest in
660
share increments over four (4) years commencing
January 2, 2016
;
|
|
•
|
1,320
shares remaining unvested of an original grant of
1,760
shares granted on
January 5, 2016
, which vest in
440
share increments over four (4) years commencing
January 5, 2017
; and
|
|
•
|
1,200
shares granted on
January 3, 2017
which vest in
300
share increments over four (4) years commencing
January 3, 2018
.
|
|
(24)
|
The details of the restricted stock grants for all Executives holding
5,500
shares of Restricted Stock as of February 15, 2017 are as follows:
|
|
•
|
550
shares remaining unvested of an original grant of
2,200
shares granted on
March 5, 2013
, which vest in
550
share increments over four (4) years commencing
March 5, 2014
;
|
|
•
|
1,100
shares remaining unvested of an original grant of
2,200
shares granted on
March 3, 2014
, which vest in
550
share increments over four (4) years commencing
March 3, 2015
;
|
|
•
|
1,650
shares remaining unvested of an original grant of
2,200
shares granted on
March 17, 2015
, which vest in
550
share increments over four (4) years commencing
March 17, 2016
; and
|
|
•
|
2,200
shares granted on
February 25, 2016
which vest in
550
share increments over four (4) years commencing
February 25, 2017
.
|
|
(25)
|
The details of the restricted stock grants for all Directors holding
10,670
shares of Restricted Stock as of February 15, 2017 are as follows:
|
|
•
|
2,750
shares remaining unvested of an original grant of
11,000
shares granted on
March 5, 2013
, which vest in
2,750
share increments over four (4) years commencing
March 5, 2014
;
|
|
•
|
1,100
shares remaining unvested of an original grant of
2,200
shares granted on
March 27, 2014
, which vest in
550
share increments over four (4) years commencing
March 27, 2015
;
|
|
•
|
1,320
shares remaining unvested of an original grant of
2,640
shares granted on
January 29, 2015
, which vest in
660
share increments over four (4) years commencing
January 29, 2016
; and
|
|
•
|
5,500
shares granted on
February 25, 2016
which vest in
1,375 thousand
share increments over four (4) years commencing
February 25, 2017
.
|
|
(26)
|
The details of the restricted stock grants for all Executives holding
4,950
shares of Restricted Stock as of February 15, 2017 are as follows:
|
|
•
|
1,100
shares remaining unvested of an original grant of
2,200
shares granted on
March 3, 2014
, which vest in
550
share increments over four (4) years commencing
March 3, 2015
;
|
|
•
|
1,650
shares remaining unvested of an original grant of
2,200
shares granted on
March 17, 2015
, which vest in
550
share increments over four (4) years commencing
March 17, 2016
; and
|
|
•
|
2,200
shares granted on
February 25, 2016
which vest in
550
share increments over four (4) years commencing
February 25, 2017
.
|
|
Name and Principal Position
|
Year
|
Salary ($)
|
Bonus ($)
|
Stock Awards ($)*
|
Option Awards ($)**
|
Non-equity Incentive Plan Compensation
|
All Other Compensation ($)
|
Total ($)
|
||||||||
|
|
|
|
(1)
|
(2)
|
(2)
|
|
|
|
|
|||||||
|
James A. Hughes
|
2016
|
400,010
|
|
151,320
|
|
49,200
|
|
26,314
|
|
—
|
|
127,534
|
|
(3)
|
754,378
|
|
|
President/CEO
|
2015
|
312,000
|
|
125,625
|
|
21,864
|
|
39,214
|
|
—
|
|
944,774
|
|
|
1,443,477
|
|
|
Alan J. Bedner
|
2016
|
199,498
|
|
60,839
|
|
19,680
|
|
26,314
|
|
—
|
|
40,695
|
|
(4)
|
347,026
|
|
|
EVP/CFO
|
2015
|
193,674
|
|
56,938
|
|
18,220
|
|
37,801
|
|
—
|
|
8,522
|
|
|
315,155
|
|
|
John J. Kauchak
|
2016
|
183,456
|
|
66,751
|
|
19,680
|
|
26,314
|
|
—
|
|
38,690
|
|
(5)
|
334,892
|
|
|
EVP/COO
|
2015
|
178,100
|
|
54,301
|
|
18,220
|
|
37,801
|
|
—
|
|
8,866
|
|
|
297,288
|
|
|
(1)
|
Mr. Hughes' 2016 bonus includes
$75,660
which has been deposited into his deferred compensation plan.
|
|
(2)
|
Represents the full grant date fair value of the award. See Note 18 to our audited financial statements. The awards are subject to vesting requirements.
|
|
(3)
|
Mr. Hughes’ other compensation for
2016
consisted of: $
1,731
for personal use of a country club membership; $
3,091
for personal use of a company automobile; $
10,720
company matching contribution to his 401(k); $
12,698
interest earned on his deferred compensation plan; and $
99,294
allocated under the SERP plan. For
2015
other compensation consisted of: $
2,831
for personal use of a company automobile; $
8,872
interest earned on his deferred compensation plan; $
9,628
company matching contribution to his 401(k); and $
923,443
allocated under the SERP plan, of which $830,000 was related to a prior service catchup while the balance represented the current year expense of this benefit.
|
|
(4)
|
Mr. Bedner’s other compensation for
2016
consisted of: $
334
for personal use of a country club membership; a $
9,975
Company matching contribution to his 401(k); and a $
30,386
contribution to a retirement plan. For
2015
other compensation consisted of: $
486
for personal use of a country club membership and an $
8,036
company matching contribution to his 401(k).
|
|
(5)
|
Mr. Kauchak’s other compensation for
2016
consisted of: $
1,989
interest earned on his deferred compensation plan; $
8,759
for company matching contribution to his 401(k); and a $
27,942
contribution to a retirement plan. For
2015
other compensation consisted of: $
1,798
interest earned on his deferred compensation plan and $
7,068
for Company matching contribution to his 401(k).
|
|
Name
|
Plan
|
Executive Contributions in Last FY ($)
|
Registrant Contributions in Last FY ($)
|
Aggregate Earnings in Last FY ($)
|
Aggregate Withdrawals/Distributions ($)
|
Aggregate balance at last FYE ($)
|
|||||
|
James A Hughes
|
SERP
|
—
|
|
99,294
|
|
—
|
|
—
|
|
1,022,737
|
|
|
Name
|
Plan
|
Executive Contributions in Last FY ($)
|
Registrant Contributions in Last FY ($)
|
Aggregate Earnings in Last FY ($)
|
Aggregate Withdrawals/Distributions ($)
|
Aggregate balance at last FYE ($)
|
|||||
|
Alan J. Bedner
|
EIRP
|
—
|
|
30,386
|
|
—
|
|
—
|
|
30,386
|
|
|
John J. Kauchak
|
EIRP
|
—
|
|
27,942
|
|
—
|
|
—
|
|
27,942
|
|
|
OPTION EQUITY AWARDS AT FISCAL YEAR-END (12/31/16)
|
|||||||||||||||||
|
Option Awards
|
Stock Awards
|
||||||||||||||||
|
Name
|
Number of Securities Underlying Unexercised Options Exercisable (#)
|
Number of Securities Underlying Unexercised Options Unexercisable (#)
|
Equity Incentive Plan Awards; Number of Securities Underlying Unexercised Unearned Options (#)
|
Option Exercise Price ($)
|
Option Expiration Date
|
Number of Shares or Units of Stock That Have Not Vested (#)
|
Market Value of Shares or Units of Stock That Have Not Vested ($)
|
Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested (#)
|
Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested (#)
|
||||||||
|
James A. Hughes
|
8,085
|
|
—
|
|
—
|
|
7.00
|
|
2/28/2018
|
2,750
|
|
43,175
|
|
—
|
|
—
|
|
|
|
3,465
|
|
—
|
|
—
|
|
6.80
|
|
4/2/2018
|
1,100
|
|
17,270
|
|
—
|
|
—
|
|
|
|
7,333
|
|
3,667
|
|
—
|
|
7.25
|
|
3/27/2024
|
1,980
|
|
31,086
|
|
—
|
|
—
|
|
|
|
3,667
|
|
7,333
|
|
—
|
|
8.31
|
|
1/29/2025
|
5,500
|
|
86,350
|
|
—
|
|
—
|
|
|
|
—
|
|
11,000
|
|
—
|
|
8.95
|
|
2/25/2026
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Alan J. Bedner
|
16,500
|
|
—
|
|
—
|
|
6.06
|
|
5/26/2021
|
550
|
|
8,635
|
|
—
|
|
—
|
|
|
|
16,500
|
|
—
|
|
—
|
|
5.82
|
|
11/17/2021
|
1,100
|
|
17,270
|
|
—
|
|
—
|
|
|
|
16,500
|
|
—
|
|
—
|
|
5.48
|
|
3/5/2023
|
1,650
|
|
25,905
|
|
—
|
|
—
|
|
|
|
7,333
|
|
3,667
|
|
—
|
|
7.16
|
|
3/3/2024
|
2,200
|
|
34,540
|
|
—
|
|
—
|
|
|
|
3,667
|
|
7,333
|
|
—
|
|
8.29
|
|
3/17/2025
|
|
|
|
|
||||
|
|
—
|
|
11,000
|
|
—
|
|
8.95
|
|
2/25/2026
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
John J. Kauchak
|
8,085
|
|
—
|
|
—
|
|
7.00
|
|
2/28/2018
|
550
|
|
8,635
|
|
—
|
|
—
|
|
|
|
8,800
|
|
—
|
|
—
|
|
3.62
|
|
12/10/2019
|
1,100
|
|
17,270
|
|
—
|
|
—
|
|
|
|
11,000
|
|
—
|
|
—
|
|
6.06
|
|
5/26/2021
|
1,650
|
|
25,905
|
|
—
|
|
—
|
|
|
|
11,000
|
|
—
|
|
—
|
|
5.82
|
|
11/17/2021
|
2,200
|
|
34,540
|
|
—
|
|
—
|
|
|
|
11,000
|
|
—
|
|
—
|
|
5.48
|
|
3/5/2023
|
|
|
|
|
||||
|
|
7,333
|
|
3,667
|
|
—
|
|
7.16
|
|
3/3/2024
|
|
|
|
|
||||
|
|
3,667
|
|
7,333
|
|
—
|
|
8.29
|
|
3/17/2025
|
|
|
|
|
||||
|
|
—
|
|
11,000
|
|
—
|
|
8.95
|
|
2/25/2026
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Payments and Benefits
|
Termination without cause
|
Termination following a change in control
|
||||
|
Cash Compensation
|
$
|
600,015
|
|
$
|
826,995
|
|
|
Health Benefits
|
18,113
|
|
18,113
|
|
||
|
Accelerated Option Vesting
|
—
|
|
61,725
|
|
||
|
Accelerated Restricted Stock Vesting
|
—
|
|
88,672
|
|
||
|
SERP Contribution
|
—
|
|
1,049,494
|
|
||
|
Total
|
$
|
618,128
|
|
$
|
2,044,998
|
|
|
Payments and Benefits
|
Termination without cause
|
Termination following a change in control
|
||||
|
Cash Compensation
|
$
|
199,498
|
|
$
|
459,835
|
|
|
Health Benefits
|
12,333
|
|
24,666
|
|
||
|
Accelerated Vesting of Stock Options
|
—
|
|
61,925
|
|
||
|
Accelerated Vesting of Restricted Stock
|
—
|
|
44,225
|
|
||
|
Total
|
$
|
211,831
|
|
$
|
590,651
|
|
|
Payments and Benefits
|
Termination without cause
|
Termination following a change in control
|
||||
|
Cash Compensation
|
$
|
183,456
|
|
$
|
433,663
|
|
|
Health Benefits
|
6,430
|
|
12,860
|
|
||
|
Accelerated Vesting of Stock Options
|
—
|
|
61,925
|
|
||
|
Accelerated Vesting of Restricted Stock
|
—
|
|
44,225
|
|
||
|
Total
|
$
|
189,886
|
|
$
|
552,673
|
|
|
Director Compensation
|
||||||||||
|
Name
|
Fees Earned or Paid in Cash ($)
|
Stock Awards ($) *
|
Option Awards ($) *
|
All Other Compensation ($) **
|
Total ($)
|
|||||
|
Dr. Mark S. Brody (1)
|
13,700
|
|
19,290
|
|
16,896
|
|
12,000
|
|
61,886
|
|
|
Wayne Courtright (2)
|
19,200
|
|
19,290
|
|
16,896
|
|
12,000
|
|
67,386
|
|
|
Dave D. Dallas (3)
|
19,500
|
|
19,290
|
|
16,896
|
|
12,000
|
|
67,686
|
|
|
Robert H. Dallas, II (4)
|
16,900
|
|
19,290
|
|
16,896
|
|
12,000
|
|
65,086
|
|
|
Dr. Mary E. Gross (5)
|
14,500
|
|
19,290
|
|
16,896
|
|
12,000
|
|
62,686
|
|
|
Dr. Austin H. Kutscher, Jr. (6)
|
10,800
|
|
19,290
|
|
16,896
|
|
12,000
|
|
58,986
|
|
|
Peter E. Maricondo (7)
|
15,900
|
|
19,290
|
|
16,896
|
|
12,000
|
|
64,086
|
|
|
Raj Patel (8)
|
16,600
|
|
19,290
|
|
16,896
|
|
12,000
|
|
64,786
|
|
|
Donald E. Souders, Jr. (9)
|
10,400
|
|
19,290
|
|
16,896
|
|
12,000
|
|
58,586
|
|
|
Aaron Tucker (10)
|
17,700
|
|
19,290
|
|
16,896
|
|
12,000
|
|
65,886
|
|
|
Allen Tucker (11)
|
22,300
|
|
19,290
|
|
16,896
|
|
12,000
|
|
70,486
|
|
|
(1)
|
At
December 31, 2016
, Dr. Brody held exercisable options to purchase
13,420
shares of stock.
|
|
(2)
|
At
December 31, 2016
, Mr. Courtright held exercisable options to purchase
13,420
shares of stock.
|
|
(3)
|
At
December 31, 2016
, Mr. D. Dallas held exercisable options to purchase
16,452
shares of stock.
|
|
(4)
|
At
December 31, 2016
, Mr. R. Dallas II held exercisable options to purchase
16,452
shares of stock.
|
|
(5)
|
At
December 31, 2016
, Dr. Gross held no exercisable options to purchase stock.
|
|
(6)
|
At
December 31, 2016
, Dr. Kutscher held no exercisable options to purchase stock.
|
|
(7)
|
At
December 31, 2016
, Mr. Maricondo held exercisable options to purchase
13,420
shares of stock.
|
|
(8)
|
At
December 31, 2016
, Mr. Patel held exercisable options to purchase
8,800
shares of stock.
|
|
(9)
|
At
December 31, 2016
, Mr. Souders held exercisable options to purchase
13,420
shares of stock.
|
|
(10)
|
At
December 31, 2016
, Mr. Aaron Tucker held no exercisable options to purchase stock.
|
|
(11)
|
At
December 31, 2016
, Mr. Allen Tucker held exercisable options to purchase
8,800
shares of stock.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|